Try our Advanced Search for more refined results
Mergers & Acquisitions
-
January 13, 2026
Medical Device Co. Faces New Derivative Suit In Delaware
A stockholder of digital health equipment business Butterfly Network Inc. launched a derivative suit in Delaware's Court of Chancery on Tuesday, seeking recovery for the company of "many millions" tied to allegedly misleading disclosures ahead of a special purpose acquisition company take-public merger in 2021.
-
January 13, 2026
2 Firms Advise On US Bancorp's Up To $1B BTIG Deal
Sullivan & Cromwell LLP is advising U.S. Bancorp on its up to $1 billion agreement to acquire Kirkland & Ellis LLP-advised financial services firm BTIG LLC, U.S. Bancorp announced Tuesday.
-
January 13, 2026
Chancery OKs $4.85M Deal To End Ed-Tech Acquisition Suit
The Delaware Chancery Court signed off Tuesday on a $4.85 million class settlement resolving stockholder claims over Sterling Partners' 2024 take-private acquisition of Australian education-technology company Keypath Education International Inc., finding that the deal fell within a reasonable range given the risks the investors faced in continuing to litigate their fiduciary-duty claims.
-
January 13, 2026
AI Infrastructure Firm Exascale To Go Public Via $500M Deal
Exascale Labs Inc., an artificial intelligence computing infrastructure platform, has announced plans to go public through a $500 million merger with special purpose acquisition company D. Boral ARC Acquisition I Corp.
-
January 13, 2026
REITs Say $787M Merger's Proxy Info Not Misleading
Real estate investment trusts Ready Capital Corp. and Broadmark Realty Capital Inc. urged a Washington federal court on Tuesday to toss a proposed shareholder class action accusing the companies of misleading shareholders to get votes for their $787 million merger, arguing the relevant proxy materials fully informed shareholders about the deal before they voted.
-
January 13, 2026
J&J Wins Partial Reversal Of $1B Merger Milestone Loss
Delaware's Supreme Court has partially reversed a vice chancellor's September 2024 ruling that Johnson & Johnson owes more than $1 billion for failing to prioritize regulatory approvals linked to "earnout" payments for robotic surgical device technology that J&J acquired from a developer.
-
January 13, 2026
Eventbrite Stockholders Sue To Block $500M Take-Private Deal
A class of Eventbrite stockholders has sued in the Delaware Chancery Court seeking to upend a pending $500 million take-private deal, arguing that a voting agreement signed alongside the transaction automatically stripped the company's founder of her super-voting control under the company's own charter and rendered the merger proxy materially misleading.
-
January 13, 2026
Wilson Sonsini Guides Polygon Labs On $250M Crypto Deals
Wilson Sonsini Goodrich & Rosati PC-advised Polygon Labs said Tuesday it has agreed to acquire crypto payments company Coinme and crypto infrastructure provider Sequence for more than $250 million, as it seeks to build a regulated stablecoin payments platform in the U.S.
-
January 12, 2026
CareFirst Opposes J&J's Bid To Revisit Stelara Antitrust Case
Insurer CareFirst urged a Virginia federal court to reject Johnson & Johnson's bid for reconsideration of a ruling that refused to toss antitrust and patent fraud claims over the immunosuppressive drug Stelara.
-
January 12, 2026
Rivals Say UP, Norfolk Southern Hiding Key Merger Details
Rival railroads have claimed that Union Pacific and Norfolk Southern are hiding crucial details about the risks and other competitive effects of their proposed mega-merger, saying the Surface Transportation Board should force the rail giants to make candid disclosures or reject their merger application altogether.
-
January 12, 2026
Paramount Sues In Del. For Warner Bros., Netflix Merger Facts
Paramount Skydance Corp. sued Warner Bros. Discovery Inc. in Delaware Chancery Court Monday for court-compelled disclosure of more details on WBD's proposed $82.7 billion tie-up with Netflix, and reported that it plans to run a slate of candidates for WBD's board to push Paramount's offer.
-
January 12, 2026
REITs Say Shareholders' Retooled Liquidation Suit Still Fails
A group of retail-focused real estate investment trusts urged a New Jersey federal court to toss an amended shareholder class action that accuses them of misleading shareholders into approving charter amendments that stopped the planned liquidation of the REITs, arguing that the amended suit repeats claims that were previously tossed.
-
January 12, 2026
Chancery Tosses Repsol Claims Against Winston & Strawn
The Delaware Chancery Court on Monday dismissed counterclaims brought by Repsol Renewables North America Inc. against Winston & Strawn LLP and one of its partners, ruling that Delaware law does not permit contract-based aiding-and-abetting claims and that Winston & Strawn did not owe fiduciary duties to a minority member in a limited liability company.
-
January 12, 2026
Adviser Claims REIT Stiffed It Over $2.1B Take-Private Deal
An advising firm has sued Plymouth Industrial REIT Inc. in Massachusetts state court, claiming the real estate investment trust is dodging its obligation to pay the adviser for helping the firm land a $2.1 billion acquisition offer.
-
January 12, 2026
FCC Scraps Verizon's 60-Day Phone Unlocking Mandate
The Federal Communications Commission on Monday waived a rule stemming from Verizon's takeover of discount provider TracFone that forced the company to open its cellphones to other carriers after 60 days.
-
January 12, 2026
Skadden, Milbank Advise On Allegiant's $1.5B Airline Deal
Skadden and Milbank are advising on a transaction that will see U.S. discount air carrier Allegiant purchase rival Sun Country Airlines in a cash and stock deal valuing the Minneapolis-based airline at about $1.5 billion.
-
January 12, 2026
Sidley-Led Smith & Nephew Inks $450M Orthopaedics Deal
Sidley Austin-advised Smith & Nephew said Monday it will acquire Gunderson Dettmer-led U.S. sports medicine company Integrity Orthopaedics and its Tendon Seam rotator cuff repair technology in a deal valued at up to $450 million.
-
January 12, 2026
Joint Cannabis Firms Settle Antitrust, 'Gun Jumping' Claims
Four Connecticut cannabis companies and their principals have agreed to pay $416,000 to settle claims that they violated state marijuana, antitrust and unfair trade practices laws by skipping a mandatory merger review process, the attorney general's office said Monday.
-
January 12, 2026
Clifford Chance Continues US Growth With Freshfields Atty
Clifford Chance LLP announced Monday that it is continuing to grow in the U.S. with the hiring of a private equity attorney from Freshfields LLP, touting her experience in cross-border mergers and acquisitions, leveraged buyouts, investments, divestitures, joint ventures, equity financings and restructurings.
-
January 12, 2026
Supreme Court Won't Disturb 9th Circ. Severance Suit Revival
The U.S. Supreme Court refused Monday to disturb a Ninth Circuit ruling that restarted two former microchip manufacturer employees' class action alleging their employer illegally revoked severance benefits following a merger, turning down an employer-side petition for review of the case.
-
January 12, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court closed out the week with developments ranging from leadership changes in a $13 billion take-private case and posttrial sparring over a major earnout to fresh governance fights, revived fraud claims and sanctions tied to advancement rights.
-
January 12, 2026
EQT To Sell Stake In Irish Biz To Haemonetics In €185M Deal
European venture capital firm EQT Life Sciences said Monday that it has sold its stake in Irish biotechnology company Vivasure Medical to Haemonetics Corp., which has acquired the whole business for up to €185 million ($216.3 million).
-
January 09, 2026
Ex-DOJ Civil Antitrust Head Joins WilmerHale
WilmerHale announced Monday it hired Ryan Danks, who until last month had headed up the U.S. Department of Justice Antitrust Division's civil enforcement program, as a new partner.
-
January 09, 2026
Bernstein Litowitz Asks To Exit $13B Endeavor Stock Suit
Bernstein Litowitz Berger & Grossmann LLP asked the Delaware Chancery Court on Friday to allow its attorneys to withdraw as lead co-counsel for the shareholder class action over sports and entertainment company Endeavor Group Holdings Inc.'s $13 billion take-private merger.
-
January 09, 2026
Ready Capital, Broadmark Want Securities Suit Moved To NY
Two real estate investment trusts and other parties urged a Washington federal court to transfer the proposed securities class action they're facing to New York federal court, arguing that the move is needed because the suit overlaps with a case in that state.
Expert Analysis
-
Dupes Boom Spurs IP Risks, Opportunities For Investors
The rising popularity of dupe products has created a dynamic marketplace where both dupes-based businesses and established branded companies can thrive, but investors must consider a host of legal implications, especially when the dupes straddle a fine line between imitation and intellectual property infringement, say attorneys at Ropes & Gray.
-
How Trump's Trade Policies Are Shaping Foreign Investment
Five months into the Trump administration, investors are beginning to see the concrete effects of the president’s America First Investment Policy as it presents new opportunities for clearing transactions more quickly, while sustaining risk aversion related to Chinese trade and potentially creating different political risks, say attorneys at Covington.
-
Series
My Opera And Baseball Careers Make Me A Better Lawyer
Though participating in opera and the world of professional baseball often pulls me away from the office, my avocations improve my legal career by helping me perform under scrutiny, prioritize team success, and maintain joy and perspective at work, says Adam Unger at Herrick Feinstein.
-
FTC Focus: Enforcers Study AI Innovation And Entrenchment
The Federal Trade Commission and other regulators setting their sights on the burgeoning artificial intelligence ecosystem are considering how the government should approach innovation in tech markets that tend, almost inevitably, toward concentration, say attorneys at Proskauer.
-
8 Ways Lawyers Can Protect The Rule Of Law In Their Work
Whether they are concerned with judicial independence, regulatory predictability or client confidence, lawyers can take specific meaningful actions on their own when traditional structures are too slow or too compromised to respond, says Angeli Patel at the Berkeley Center of Law and Business.
-
Assessing New Changes To Texas Officer Exculpation Law
Consistent with Texas' recent modernization of its corporate law, the recently passed S.B. 2411 allows officer exculpation, streamlines certificate of formation amendments, authorizes representatives to act on shareholders' behalf in mergers and makes other changes aimed toward companies seeking a more codified, statutory model of corporate governance, say attorneys at Bracewell.
-
Series
Law School's Missed Lessons: Communicating With Clients
Law school curricula often overlook client communication procedures, and those who actively teach this crucial facet of the practice can create exceptional client satisfaction and success, says Patrick Hanson at Wiggam Law.
-
Series
Adapting To Private Practice: From US Rep. To Boutique Firm
My transition from serving as a member of Congress to becoming a partner at a boutique firm has been remarkably smooth, in part because I never stopped exercising my legal muscles, maintained relationships with my former colleagues and set the right tone at the outset, says Mondaire Jones at Friedman Kaplan.
-
Spinoff Transaction Considerations For Biotech M&A
Amid current market challenges, boards and management teams of biotech companies can consider several strategies for maximizing value should a spinoff opportunity arise, but not without significant advance planning and careful implementation, particularly in cases that might qualify as tax-free, say attorneys at Paul Hastings.
-
Opinion
Senate's 41% Litigation Finance Tax Would Hurt Legal System
The Senate’s latest version of the Big Beautiful Bill Act would impose a 41% tax on the litigation finance industry, but the tax is totally disconnected from the concerns it purports to address, and it would set the country back to a time when small plaintiffs had little recourse against big defendants, says Anthony Sebok at Cardozo School of Law.
-
Series
Performing As A Clown Makes Me A Better Lawyer
To say that being a clown in the Macy’s Thanksgiving Day Parade has changed my legal career would truly be an understatement — by creating an opening to converse on a unique topic, it has allowed me to connect with clients, counsel and even judges on a deeper level, says Charles Tatelbaum at Tripp Scott.
-
Series
Law School's Missed Lessons: Rejecting Biz Dev Myths
Law schools don’t spend sufficient time dispelling certain myths that prevent young lawyers from exploring new business opportunities, but by dismissing these misguided beliefs, even an introverted first-year associate with a small network of contacts can find long-term success, says Ronald Levine at Herrick Feinstein.
-
Del. Dispatch: General Partner Discretion In Valuing Incentives
In Walker v. FRP Investors, the Delaware Court of Chancery recently held that the general partner of a limited partnership breached its obligations when determining the threshold value of newly issued incentive units, highlighting the court's willingness to reconstruct what a reasonable determination of value by a general partner should have been, say attorneys at Fried Frank.
-
Move Beyond Surface-Level Edits To Master Legal Writing
Recent instances in which attorneys filed briefs containing artificial intelligence hallucinations offer a stark reminder that effective revision isn’t just about superficial details like grammar — it requires attorneys to critically engage with their writing and analyze their rhetorical choices, says Ivy Grey at WordRake.
-
How Ore. Law Puts New Confines On Corp. Health Ownership
A newly enacted law in Oregon strengthens the state’s restrictions on corporate ownership of healthcare practices, with new limitations on overlapping control, permissible services, restrictive covenants and more making it necessary for practices to review decades-old physician practice arrangements, say attorneys at Ropes & Gray.